Obesity Clinical Trial
Official title:
Pulmonary Inflammation and Microbiome Changes With Bariatric Surgery in Obese Asthma
NCT number | NCT04247971 |
Other study ID # | Pro00104326 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | April 30, 2021 |
Est. completion date | February 9, 2023 |
Verified date | February 2023 |
Source | Duke University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to gain understanding of mechanisms whereby bariatric surgery modulates pulmonary inflammation and pulmonary microbiome composition and how these changes direct the pathobiology of human obese asthma.
Status | Completed |
Enrollment | 16 |
Est. completion date | February 9, 2023 |
Est. primary completion date | February 9, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years to 60 Years |
Eligibility | Inclusion Criteria: Asthma Subjects - Outpatient adults of either sex 21-60 years of age with an initial asthma diagnosis at < 12 years of age (early-onset) or >12 years of age (late-onset), as defined by the NHLBI NAEPP guidelines (17). - Subjects with obesity (BMI = 30 kg/m2). - Physician diagnosis of asthma. - Eligible and scheduled for bariatric surgery (Roux-en-Y gastric bypass, sleeve gastrectomy or duodenal switch) and receiving care within the Duke Health System. FEV1 within acceptable limits (>45% predicted before and >55% predicted after, bronchodilator administration). - Relatively healthy subjects able to undergo sputum induction without complications. - Willing and able to give informed consent and adhere to visit/protocol schedules. - Read and write in English. Non-Asthma Control Subjects - Outpatient adults of either sex 21-60 years of age. - Subjects with obesity (BMI = 30). - Eligible and scheduled for bariatric surgery (Roux-en-Y gastric bypass, sleeve gastrectomy or duodenal switch) at Duke Regional Hospital and receiving care at the Duke Metabolic and -Weight Loss Surgery Center. - Normal lung function. - No clinical history of atopy. - No significant medical or psychological issues. - Healthy subjects able to undergo sputum induction without complications. - Willing and able to give informed consent and adhere to visit/protocol schedules. - Read and write in English. Exclusion Criteria: - Children < 21 years of age. - Inpatient status. - Ineligibility or not scheduled for bariatric surgery at the Duke Metabolic and Weight Loss Surgery Center. - FEV1 is less than 45% predicted before, or less than 55% predicted after, bronchodilator administration. - Upper or lower respiratory tract infection within one month of the study. - Use of systemic corticosteroids within four weeks of study. - Smoking (tobacco, e-cigarette, vaping or inhaled drugs) history > 5 pack years or smoking or vaping within the previous six months. - Significant non-asthma pulmonary disease (stable obstructive sleep apnea is not excluded). - An ED visit or inpatient admission for a primary respiratory diagnosis within 60 days of enrollment. - Poorly controlled concomitant conditions that pose additional procedure risk as determined by the investigator. - All patients on anticoagulants. - Uncontrolled sleep apnea. |
Country | Name | City | State |
---|---|---|---|
United States | Duke University | Durham | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Duke University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in leptin levels | Baseline (2 weeks before surgery), 30 days post-surgery, 3 months post-surgery | ||
Primary | Change in adiponectin levels | Baseline (2 weeks before surgery), 30 days post-surgery, 3 months post-surgery | ||
Primary | Change in IL-8 levels | Baseline (2 weeks before surgery), 30 days post-surgery, 3 months post-surgery | ||
Primary | Change in IL-6 levels | Baseline (2 weeks before surgery), 30 days post-surgery, 3 months post-surgery | ||
Primary | Change in cystatin-c levels | Baseline (2 weeks before surgery), 30 days post-surgery, 3 months post-surgery | ||
Primary | Change in IL-17 levels | Baseline (2 weeks before surgery), 30 days post-surgery, 3 months post-surgery | ||
Primary | Change in IL-1beta levels | Baseline (2 weeks before surgery), 30 days post-surgery, 3 months post-surgery | ||
Primary | Change in TNF-a levels | Baseline (2 weeks before surgery), 30 days post-surgery, 3 months post-surgery | ||
Primary | Change in YKL-40 levels | Baseline (2 weeks before surgery), 30 days post-surgery, 3 months post-surgery | ||
Primary | Change in lung function as measured by forced expiratory volume | Baseline (2 weeks before surgery), 30 days post-surgery, 3 months post-surgery | ||
Primary | Change in lung function as measured by forced vital capacity | Baseline (2 weeks before surgery), 30 days post-surgery, 3 months post-surgery | ||
Primary | Change in lung function as measured by fractional concentration of exhaled nitro oxide | Baseline (2 weeks before surgery), 30 days post-surgery, 3 months post-surgery | ||
Primary | Change in lung function as measured by FEV1/FVC | Baseline (2 weeks before surgery), 30 days post-surgery, 3 months post-surgery | ||
Primary | Change in lung function as measured by forced expiratory flow | Baseline (2 weeks before surgery), 30 days post-surgery, 3 months post-surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |